First Trust Advisors LP Decreases Position in Fresenius Medical Care Corporation (FMS)

First Trust Advisors LP trimmed its holdings in shares of Fresenius Medical Care Corporation (NYSE:FMS) by 1.5% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 105,700 shares of the company’s stock after selling 1,583 shares during the period. First Trust Advisors LP’s holdings in Fresenius Medical Care Corporation were worth $5,168,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also made changes to their positions in the stock. UBS Asset Management Americas Inc. boosted its position in Fresenius Medical Care Corporation by 3.6% in the 2nd quarter. UBS Asset Management Americas Inc. now owns 2,357 shares of the company’s stock valued at $114,000 after buying an additional 81 shares during the last quarter. Pacer Advisors Inc. purchased a new position in Fresenius Medical Care Corporation in the 2nd quarter valued at about $179,000. FFT Wealth Management LLC purchased a new position in Fresenius Medical Care Corporation in the 2nd quarter valued at about $201,000. HPM Partners LLC purchased a new position in Fresenius Medical Care Corporation in the 2nd quarter valued at about $221,000. Finally, YorkBridge Wealth Partners LLC boosted its position in Fresenius Medical Care Corporation by 19.4% in the 2nd quarter. YorkBridge Wealth Partners LLC now owns 4,613 shares of the company’s stock valued at $222,000 after buying an additional 749 shares during the last quarter. 2.62% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: This news story was originally published by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The correct version of this news story can be accessed at https://sportsperspectives.com/2017/11/17/first-trust-advisors-lp-decreases-position-in-fresenius-medical-care-corporation-fms.html.

Shares of Fresenius Medical Care Corporation (NYSE:FMS) opened at $49.15 on Friday. The stock has a market cap of $29,850.20, a PE ratio of 21.74, a PEG ratio of 2.19 and a beta of 0.45. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.22 and a quick ratio of 0.98. Fresenius Medical Care Corporation has a 12 month low of $38.05 and a 12 month high of $50.22.

A number of equities analysts have weighed in on the stock. Zacks Investment Research cut shares of Fresenius Medical Care Corporation from a “hold” rating to a “sell” rating in a research report on Tuesday, October 3rd. BidaskClub cut shares of Fresenius Medical Care Corporation from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 24th. Royal Bank Of Canada reissued a “neutral” rating and issued a price objective on shares of Fresenius Medical Care Corporation in a research report on Tuesday, August 8th. Finally, DZ Bank AG reissued a “buy” rating on shares of Fresenius Medical Care Corporation in a research report on Monday. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and four have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $48.50.

About Fresenius Medical Care Corporation

Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.

Institutional Ownership by Quarter for Fresenius Medical Care Corporation (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply